Phenotype and genotype in polycystic ovary syndrome

Polycystic Ovary Syndrome, Second Edition

Volumn , Issue , 2007, Pages 25-41

  Legro, Richard S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949278538     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545191.003     Document Type: Chapter

References (56)

1. Azziz R., Dewailly D., and Owerbach D. (1994) Clinical review 56: nonclassic adrenal hyperplasia: current concepts. J. Clin. Endocrinol. Metab. 78:810-815.
2. Azziz R., Woods K. S., Reyna R., et al. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89:2745-2749.
3. Balen A. H., Laven J. S., Tan S. L., and Dewailly D. (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum. Reprod. Update 9:505-514.
4. Cardon L. R. and Bell J. I. (2001) Association study designs for complex diseases. Nat. Rev. Genet. 2:91-99.
5. Carey A. H., Chan K. L., Short F., et al. (1993) Evidence for a single gene eVect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf.) 38:653-658.
6. Carmina E., Koyama T., Chang L., Stanczyk F. Z., and Lobo R. A. (1992) Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am. J. Obstet. Gynecol. 167:1807-1812.
7. Cooper H. E., Spellacy W. N., Prem K. A., and Cohen W.D. (1968) Heriditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 100:371-387.
8. Cousin P., Calemard-Michel L., Lejeune H., et al. (2004) Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. J. Clin. Endocrinol. Metab. 89:917-924.
9. Diamanti-Kandarakis E., Kouli C. R., Bergiele A. T., et al. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J. Clin. Endocrinol. Metab. 84:4006-4011.
10. Diamanti-Kandarakis E., Bartzis M. I., Bergiele A. T., Tsianateli T. C., and Kouli C. R. (2000) Microsatellite polymorphism (TTTTA)(n) at 528 base pairs of gene CYP11a influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil. Steril. 73:735-741.
11. Dunaif A., Sorbara L., Delson R., and Green G. (1993) Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes 42:1462-1468.
12. Ehrmann D. A., Schwarz P. E., Hara M., et al. (2003) Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87:1669-1673.
13. El Mkadem S. A., Lautier C., Macari F., et al. (2001) Role of allelic variants gly972arg of irs-1 and gly1057asp of irs-2 in moderate to severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50:2164-2168.
14. Escobar-Morreale H. F., Roldan B., Barrio R., et al. (2000) High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 85:4182-4187.
15. Ferriman D. and Purdie A.W. (1979) The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin. Endocrinol. (Oxf.) 11:291-300.
16. Gaasenbeek M., Powell B. L., Sovio U., et al. (2004) Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J. Clin. Endocrinol. Metab. 89:2408-2413.
17. Garg A. (2004) Acquired and inherited lipodystrophies. N. Engl. J. Med. 350:1220-1234.
18. Gharani N., Waterworth D. M., Williamson R., and Franks S. (1996) 5 0 Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J. Clin. Endocrinol. Metab. 81:4174.
19. Gharani N., Waterworth D. M., Batty S., et al. (1997) Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum.Mol. Genet. 6:397-402.
20. Gilling-Smith C., Willis D. S., Beard R.W., and Franks S. (1994) Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 79:1158-1165.
21. Govind A., Obhrai M. S., and Clayton R. N. (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J. Clin. Endocrinol. Metab. 84:38-43.
22. Hague W. M., Adams J., Reeders S. T., Peto T. E., and Jacobs H. S. (1988) Familial polycystic ovaries: a genetic disease? Clin. Endocrinol. (Oxf.) 29:593-605.
23. Hegele R. A. (2005) Lessons from human mutations in PPARgamma. Int. J. Obes. Relat. Metab. Disord. 29(Suppl. 1):S31-S35.
24. Jahanfar S., Eden J. A., Warren P., Seppala M., and Nguyen T.V. (1995) A twin study of polycystic ovary syndrome. Fertil. Steril. 63:478-486.
25. Jahanfar S., Maleki H., Mosavi A. R., and Jahanfar M. (2004) Leptin and its association with polycystic ovary syndrome: a twin study. Gynecol. Endocrinol. 18:327-334.
26. Kahsar-Miller M.D., Nixon C., Boots L. R., Go R. C., and Azziz R. (2001) Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil. Steril. 75:53-58.
27. KauVman R. P., Baker V. M., Dimarino P., Gimpel T., and Castracane V.D. (2002) Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am. J. Obstet. Gynecol. 187:1362-1369.
28. Kaushal R., Parchure N., Bano G., Kaski J. C., and Nussey S. S. (2004) Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clin. Endocrinol. (Oxf.) 60:322-328.
29. Lander E. S. and Schork N. J. (1994) Genetic dissection of complex traits. Science 265:2037-2048: erratum, Science 266:353.
30. Legro R. S. and Strauss J. F. (2002) Molecular progress in infertility: polycystic ovary syndrome. Fertil. Steril. 78:569.
31. Legro R. S., Driscoll D., Strauss Jr. J. F., Fox J., and Dunaif A. (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl Acad. Sci. U.S.A. 95: 14956-14960.
32. Legro R. S., Bentley-Lewis R., Driscoll D., Wang S. C., and Dunaif A. (2002a) Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J. Clin. Endocrinol. Metab. 87:2128-2133.
33. Legro R. S., Kunselman A. R., Demers L., et al. (2002b) Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87:2134-2138.
34. Liede A., Pal T., Mitchell M., and Narod S. A. (2000) Delineation of a new syndrome: clustering of pyloric stenosis, endometriosis, and breast cancer in two families. J.Med. Genet. 37:794-796.
35. Lunde O., Magnus P., Sandvik L., and Hoglo S. (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 28:23-30.
36. McKeigue P. and Wild S. (1997) Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Lancet 349:1771-1772.
37. Moran C., Azziz R., Carmina E., et al. (2000) 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am. J. Obstet. Gynecol. 183:1468-1474.
38. Nelson V. L., Legro R. S., Strauss J. F. III, and McAllister J. M. (1999) Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 13:946-957.
39. Norman R. J., Mahabeer S., and Masters S. (1995) Ethnic diVerences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil. Steril. 63:58-62.
40. Norman R. J., Masters S., and Hague W. (1996) Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil. Steril. 66:942-947.
41. Powell B. L., Haddad L., Bennett A., et al. (2005) Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. J. Clin. Endocrinol. Metab. 90:2988-2993.
42. San Millan J. L., Sancho J., Calvo R. M., and Escobar-Morreale H. F. (2001) Role of the pentanucleotide (TTTTA)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil. Steril. 75:797-802.
43. Sir-Petermann T., Angel B., Maliqueo M., et al. (2002) Prevalence of type 2 diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 45:959-964.
44. Sorbara L. R., Tang Z., Cama A., et al. (1994) Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome. Metabolism 43:1568-1574.
45. Spielman R. S. and Ewens W. J. (1996) The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59:983-989.
46. Talbot J. A., Bicknell E. J., Rajkhowa M., et al. (1996) Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 81:1979-1983.
47. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod. 19:41-47.
48. Tucci S., Futterweit W., Concepción E. S., et al. (2001) Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J. Clin. Endocrinol. Metab. 86:446-449.
49. Urbanek M., Legro R. S., Driscoll D. A., et al. (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl Acad. Sci. U.S.A. 96:8573-8578.
50. Urbanek M., Wu X., Vickery K. R., et al. (2000) Allelic variants of the follistatin gene in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 85:4455-4461.
51. Vigouroux C. and Capeau J. (2005) A-type lamin-linked lipodystrophies. Novartis Found. Symp. 264:166-177; discussion 177-182, 227-230.
52. Waterworth D. M., Bennett S. T., Gharani N., et al. (1997) Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349:986-990.
53. Wijeyaratne C. N., Balen A. H., Barth J. H., and Belchetz P. E. (2002) Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a diVerence? Clin. Endocrinol. (Oxf.) 57:343-350.
54. Wilroy Jr. R. S., Givens J. R., Wiser W. L., et al. (1975) Hyperthecosis: an inheritable form of polycystic ovarian disease. Birth Defects: Orig. Art. Ser. 11:81-85.
55. Yildiz B.O., Yarali H., Oguz H., and Bayraktar M. (2003) Glucose intolerance, insulin resistance, and hyperandrogenemia in first-degree relatives of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88:2031-2036.
56. Zawadski J. K. and Dunaif A. (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif A. (ed.) The Polycystic Ovary Syndrome, pp. 377-384. Cambridge, MA: Blackwell Scientific.